Delivery Order SPE2DB24D9249-SPE2DB25FGLFH

Award Date 3/21/25
Potential Completion Date 4/11/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The $2,954.65 firm fixed-price delivery order contract is for the supply of a single pharmaceutical product, the YF-VAX 1 dose vial, with a period of performance through August 30, 2024. This award is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of various pharmaceutical products. The contract, valued at $13,523.76, is for the delivery of YF-VAX 1 dose vials and has an ultimate completion date of April 29, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, supporting the recurring medical supply needs of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The $1,126.98 firm fixed-price delivery order has an ultimate completion date of October 1, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,253.96 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of YF-VAX 1 DOSE VIALS and has a period of performance through June 6, 2024. DMS Pharmaceutical Group is an experienced government contractor that provides a wide range of branded and generic pharmaceutical products, biologics, and medical supplies to support the recurring...
This federal contract award from the Defense Logistics Agency (DLA) was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,670.13 firm fixed-price delivery order contract is for the provision of YF-VAX 1 dose vials, which are specialized pharmaceutical products. The contract has an ultimate completion date of February 14, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $2,189.24 under an indefinite delivery contract with the Defense Logistics Agency to supply YF-VAX 1 DOSE VIALS. The delivery order is for completion by January 5, 2024. As a woman-owned small business and woman-owned business, DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that regularly provides medical supplies to the Defense Logistics Agency to support military treatment facilities...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order contract with a firm fixed price ceiling value of $2,817.45. The contract, SPE2DB24FK8LW, was awarded on April 2, 2024 by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 23, 2024. The contract is for the delivery of YF-VAX 1 dose vials, with no set-aside designation. DMS Pharmaceutical Group Inc. is an experienced pharmaceutical wholesaler that...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a $1,690.47 firm fixed-price delivery order placed by the Defense Logistics Agency (DLA) under the SPE2DB Indefinite Delivery Contract (IDC). The contract is for the provision of 1-dose vials of the YF-VAX vaccine, with a completion date of December 23, 2024. DMS Pharmaceutical Group holds a substantial $499,999,999 IDC with the DLA under the SPE2DB program, which enables...
This federal contract award, valued at $5,634.90, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm-fixed-price delivery order for the supply of YF-VAX 1-dose vials, with a performance period through October 10, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
The U.S. Defense Logistics Agency (DLA) awarded a $1,126.98 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of YF-VAX 1-dose vials and has a completion date of June 26, 2024. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, which allows DLA to issue delivery orders for a wide range of...
  • SPE2DB24D9249
    Indefinite Delivery Contract
  • SPE2DB24D9249-SPE2DB25FGLFH
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $2,783.55 from the Defense Logistics Agency (DLA). The award is for the supply of 4567707314 YF-VAX 1 dose vials, a specialized pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 11, 2025.

DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a wide variety of pharmaceutical products.

Generated 6/21/25, 9:43 AM